- Research article
- Open Access
- Open Peer Review
Influence of hypothermia on right atrial cardiomyocyte apoptosis in patients undergoing aortic valve replacement
© Castedo et al; licensee BioMed Central Ltd. 2007
- Received: 18 September 2006
- Accepted: 23 January 2007
- Published: 23 January 2007
There is increasing evidence that programmed cell death can be triggered during cardiopulmonary bypass (CPB) and may be involved in postoperative complications. The purpose of this study was to investigate whether apoptosis occurs during aortic valve surgery and whether modifying temperature during CPB has any influence on cardiomyocyte apoptotic death rate.
20 patients undergoing elective aortic valve replacement for aortic stenosis were randomly assigned to either moderate hypothermic (ModHT group, n = 10, 28°C) or mild hypothermic (MiHT group, n = 10, 34°C) CPB. Myocardial samples were obtained from the right atrium before and after weaning from CPB. Specimens were examined for apoptosis by flow cytometry analysis of annexin V-propidium iodide (PI) and Fas death receptor staining.
In the ModHT group, non apoptotic non necrotic cells (annexin negative, PI negative) decreased after CPB, while early apoptotic (annexin positive, PI negative) and late apoptotic or necrotic (PI positive) cells increased. In contrast, no change in the different cell populations was observed over time in the MiHT group. Fas expression rose after reperfusion in the ModHT group but not in MiHT patients, in which there was even a trend for a lower Fas staining after CPB (p = 0.08). In ModHT patients, a prolonged ischemic time tended to induce a higher increase of Fas (p = 0.061).
Our data suggest that apoptosis signal cascade is activated at early stages during aortic valve replacement under ModHT CPB. This apoptosis induction can effectively be attenuated by a more normothermic procedure.
- Propidium Iodide
- Aortic Valve Replacement
- Cardiomyocyte Apoptosis
- Mild Hypothermia
- Annexin Versus Staining
Cardiomyocyte apoptosis has been involved in the pathophysiology of various cardiovascular diseases such as ischemic cardiomyopathy, hibernating myocardium, heart failure, reperfusion injury, and transplant rejection [1, 2]. Recent reports have documented the prevalence of programmed cardiomyocyte death in open heart surgery under cardiopulmonary bypass (CPB), where it may contribute in parallel with necrosis to increase the bulk of myocardial death cells [3–12]. Apoptosis that occurs in this clinical setting can be induced by a wide variety of conditions and agents, including reactive oxygen-derived species, calcium and pressure overload, mechanical stress, nitric oxide, tumor necrosis factor, and angiotensin II [2, 13]. It remains unclear whether apoptosis is a primary or a secondary event within cardiac surgery, and while some authors have related it to postoperative myocardial stunning  and non cardiac complications [3, 4]; others have observed that inhibition of apoptosis has no impact on postischemic left ventricle functional recovery .
One of the reasons for scarce data concerning apoptosis and its pathophysiological consequences during cardiac surgery is the inferiority of the various techniques used to detect apoptotic cell changes. The most commonly used method, histochemical staining of the fragmented DNA by the TUNEL assay (in situ terminal deoxynucleotidyl-transferase mediated dUTP nick end-labeling), has a poor positive predicted value, as it labels not only fragmented DNA but also DNA in the process of repair as well as necrotic tissue [2, 15]. Besides, the duration of the apoptotic program (12 to 24 hours) far exceeds the intraoperative window for sample acquisition (2 to 3 hours) , which render the observation of late signs of apoptotic cascade like DNA fragmentation useless. The investigation of early apoptotic signs, such as the translocation of membrane phospholipids or the activation of intracellular proteins, using more accurate tools may overcome these limitations.
Rationale for the use of hypothermia during cardiac surgery is based on its capacity to reversibly reduce metabolic activity in all cells and subcellular organelles, further limiting the rate of consumption of intracellular high-energy phosphates stores and ischemic injury . Despite of this positive effect, hypothermia has also a deleterious influence on platelet function and increases citrate toxicity, with subsequent reduction in serum ionized calcium, leading to reversible coagulopathy, dysrhythmias, and depression of myocardial contractility [17, 18]. The role of temperature for apoptosis is controversial and may be dual depending on the degree of hypothermia. While deep hypothermic circulatory arrest may activate apoptotic pathways , less aggressive hypothermia seems to inhibit them . The temperature limits at which apoptosis is enhanced or attenuated should be accurately defined.
The purpose of this study was to investigate whether apoptosis occurs during elective aortic valve replacement for aortic stenosis and whether CPB temperature has any influence on cardiomyocyte apoptotic death rate. The reason for selecting non urgent isolated aortic valve patients was their greater homogeneity with respect to other cardiac pathologies, and the possibility of avoiding underlying causes of myocardial apoptosis other than cardiac surgery, such as ischemic cardiomyopathy or congestive heart failure. To adequate operative sample acquisition timing to the development of the apoptotic program we analyzed early stages apoptosis by flow cytometric analysis of annexin V and death receptor Fas staining.
Demographic, clinical, and CPB data of trial groups
ModHT Group (n = 10)
MiHT Group (n = 10)
70.6 ± 9.7
67.7 ± 12.3
Female, n (%)
Hypertension, n (%)
Smoking history, n (%)
Diabetes, n (%)
Hyperlipidemia, n (%)
Atrial fibrillation, n (%)
62.2 ± 17.1
57.8 ± 17.8
CPB time (min)
85.2 ± 11.3
87.5 ± 21.1
Aortic crossclamping time (min)
59.2 ± 7.8
59.0 ± 16.6
Minimal core CPB temperature (nasopharyngeal) (°C)
28.2 ± 1.1
34.5 ± 0.9
Need for postCPB inotropic support, n (%)
2.2. Sample acquisition
Using a sharp scalpel, myocardial biopsy specimens (approximately 300 mm3) were obtained from the right atrial appendage of each patient before the start of CPB and after weaning from extracorporeal circulation. To minimize technical influences on apoptotic and necrotic measurements, particular care was taken not to mechanically irritate the site of atrial tissue harvesting with the forceps and with the venous cannula. Blood samples were also taken from the coronary sinus at the same time of heart biopsy collection for analysis of necrosis.
2.3. Isolation of cardiomyocytes
A single cell suspension was obtained from the heart tissue samples immediately after removal by mechanical disaggregation with a 50 μm filtered Medimachine system (BD Bioscience, CA, USA). Cells were washed with cold phosphate buffer saline (PBS) to exclude cell debris and resuspended in culture medium (RPMI 1640; Bio-Whittaker, Verviers, Belgium). This procedure rendered a preserved viability cell population as judged by trypan blue dye exclusion. To be sure that cardiac cells were specifically quantified, intracellular expression of the specific protein -connexin 43- was analyzed. After fixation and permeabilization with IntraStain kit (Dako Cytomation, Glostrup, Denmark), cells were incubated with connexin 43 rabbit polyclonal antibody (Zymed Laboratories, San Francisco, CA, USA). Binding was revealed by phycoerythrin conjugated goat anti-rabbit IgG (Jackson Immunoresearch, Baltimore, USA) and flow cytometry. The antibodies were initially titrated for optimal concentration, and cells incubation with only phycoerythrin-antibody was used as negative control.
2.4. Analysis of apoptosis
Apoptosis was measured by staining cells with a combination of fluoresceinated (FITC) annexin V and propidium iodide (PI) and by Fas death receptor quantification on cell membrane.
Fas molecule (APO-1/CD95) belongs to the tumor necrosis factor receptor superfamily and may induce apoptosis by Fas-Fas ligand (Fas-L) binding. The Fas/Fas-L system is an essential part of the death receptor pathway regulating the induction of a rapid apoptosis independent of mitochondria. We measured Fas by membrane cell staining with FITC conjugated anti-CD95 monoclonal antibody (BD Biosciences) (Figure 1). Mouse IgG1 irrelevant antibody FITC conjugated was used as negative control of staining. After 15 minutes incubation at room temperature and dark, these cells were washed to remove the excess of antibody and fixed with 2% formaldehyde. Antibodies were used following manufacturer recommendations. In all cases, we have used a FACSort (BD Bioscience) flow cytometer to measure the cell-associated fluorescence with CellQuest and Paint-a-gate Pro analysis software (BD Bioscience).
2.5. Analysis of necrosis
Cardiomyocyte loss by necrosis was assessed by determination of creatine kinase, creatine kinase myocardial band, lactate dehydrogenase, troponin I, and lactate.
2.6. Statistical analysis
Data are presented as mean ± standard deviation. The χ2test and the two-tailed unpaired Student's t test were used when appropriate to compare the results between groups. Values from the different biochemical variables before and after CPB were compared using the two-tailed paired Student's t test. Correlation between the number of early apoptotic cells, Fas levels, and operative times was studied using Pearson's correlation coefficient. Differences were considered significant when p value was less than 0.05. Statistical analyses were performed with the software package SPSS for Windows, release 10.0.7 (SPSS Inc, Chicago, Ill, USA).
Groups were well matched in terms of age, sex, prevalence of cardiovascular risk factors and atrial fibrillation, preoperative left ventricular function, and duration of CPB and aortic crossclamping (Table 1).
Cell death status over time
Basal (ModHT group/MiHT group)
Reperfusion (ModHT group/MiHT group)
p Value (ModHT group/MiHT group)
Non apoptotic non necrotic cells (annexin negative, PI negative) (%)
73.86 ± 18.49/67.28 ± 16.40
51.20 ± 23.88/71.71 ± 11.35 a
Early apoptotic cells (annexin positive, PI negative) (%)
16.45 ± 13.36/20.70 ± 12.21
33.21 ± 17.85/17.62 ± 8.06 a
Late apoptotic or necrotic cells (annexin positive, PI positive) (%)
6.97 ± 3.68/10.49 ± 5.92
11.45 ± 5.11/8.90 ± 5.36
Fas positive cells (%)
15.14 ± 17.85/20.03 ± 14.99
31.34 ± 22.54/14.30 ± 10.66
53.1 ± 21.6/60.2 ± 23.7
167.1 ± 158.5/153.8 ± 87.9
29.13 ± 18.20/20.00 ± 3.62
42.25 ± 33.80/37.70 ± 12.18
363.0 ± 94.2/334.5 ± 61.6
385.4 ± 152.7/363.5 ± 80.1
Troponin I (μg/L)
0.32 ± 0.33/0.22 ± 0.15
1.48 ± 1.37/1.45 ± 0.53
1.53 ± 0.88/1.62 ± 0.91
3.60 ± 1.32/3.19 ± 1.19
Apoptosis has been reported not only to occur during open heart surgery but also to be related to postoperative myocardial stunning, renal insufficiency, and cerebral dysfunction [3, 4, 9]. Cardiac surgery combines two pro-apoptotic stimuli: ischemia-reperfusion injury and CPB. Both processes lead to the activation of vascular endothelial cells and neutrophils, thereby stimulating cellular calcium overload, and the generation of reactive oxygen-derived species and cytokines that may further initiate the apoptotic program in cardiomyocytes [2, 13]. Serum of patients after CPB has been shown to have a strong proapoptotic activity on human endothelial cells . Several recent studies have demonstrated that both the mitochondrial and the death receptor pathways of caspase activation are triggered during open heart surgery leading to myocardial apoptosis. Schmitt and coworkers found a postreperfusion highly significant 3.4 ± 0.4-fold increase of the mitochondrial respiratory chain protein -cytochrome c- in the cytosol of atrial myocytes during coronary artery bypass grafting . Activation of caspases-3 and -7 and an elevated release of soluble Fas and Fas ligand have also been detected at the end of extracorporeal circulation [6, 8, 10].
Strategies towards a less apoptogenic procedure appear to be a goal to achieve excellence in cardiac surgery and may include shortening of ischemic and CPB times, increased use of intraaortic balloon pump and noncatecholamine inotropes, addition of antiapoptotic medication, or modulation of intraoperative temperature.
Hypothermia improves resistance to ischemia-reperfusion injury in the myocardium. Protection afforded by low temperature may be linked to a wide variety of effects, including reduction of ATP store depletion, inhibition of endothelial cell expression of E-selectin, modification of cell death signaling pathways, and preservation of gene expression for mitochondrial proteins . Nevertheless, the impact of intraoperative hypothermia on cardiomyocyte apoptosis during cardiac surgical procedures remains controversial. Cooper and colleagues have observed an increased rate of apoptosis in duodenal and myocardial tissue from pigs subjected to deep hypothermic circulatory arrest as compared to normothermic CPB controls . Other authors, on the contrary, have assessed by gene array analysis a protective effect of hypothermia (30°C) on the cardioplegia-arrested rabbit heart, based on its ability for decreasing the expression of proapoptotic proteins (p53, bak) and promoting antiapoptotic factors (Bcl-x) . This finding is also supported by studies including experimental models of cerebral hypoxia in which hypothermia mitigated post-ischemic programmed cell death [20–22].
Our results suggest an additive pro-apoptotic effect of moderate hypothermia that may superimpose on the per se apoptogenic state of CPB, and that might be involved in the decreased systolic performance often observed with cooling [17, 18]. Two early reversible morphological features of apoptosis signal cascade activation, phosphatidylserine externalization and Fas expression in the plasma membrane, increased after reperfusion in the ModHT group but not in MiHT patients.
The annexin V staining as a method for cell death analysis has been mainly applied in lymphoid disorders, but there is increasing evidence that it is also useful for the detection of apoptotic cardiomyocytes [1, 23, 24]. When compared to the TUNEL assay, both methods have shown a similar sensitivity and specificity . Scholz and Leaes have recently employed annexin V technique for the analysis of neutrophil and lymphoid apoptosis that occurred during CPB in pigs and humans, respectively [11, 12]. Annexin V staining reveal phosphatidylserine outer leaflet membrane exposure, which is one of the earliest hallmarks of cells undergoing apoptosis [1, 15, 23, 24]. Annexin positive cardiomyocytes retain contractile function but exhibit a decreased cell width indicative of cell shrinkage, and a markedly elevated mitochondrial free Ca2+ . In our study, annexin V positive-PI negative cells were detected in both groups before the start of CPB, but whereas in the ModHT group the number of cardiomyocytes that had initiated the apoptotic program increased after reperfusion, in MiHT patients it remained unchanged.
The biological relevance of Fas has been mainly proved in relation to T lymphocytes activity in the context of autoimmune and hematopoietic diseases [6, 8]. Nevertheless, Fas is also expressed in other non lymphoid cells such as cardiomyocytes or hepatocytes . In fact, it has been shown to be involved in the pathophysiology of congestive heart failure, graft rejection, end-stage cardiomyopathy, and myocarditis . Kawahito and Joashi have observed elevated serum levels of the soluble form of Fas and Fas ligand after completion of cardiac surgical procedures under moderate hypothermic CPB [6, 8]. They also found prolonged operative times to induce higher serum concentrations of Fas. In the present study, a significant but similar percentage of cardiomyocytes were Fas positive before CPB in both groups. A higher Fas expression was observed after reperfusion in ModHT patients, but not in those operated under mild hypothermia, which tended to show less Fas positive cells after weaning from CPB. In addition, in the ModHT group there was a trend for a higher increase in Fas staining with longer ischemic times. Phanithi and colleagues have also demonstrated that mild hypothermia (33°C) reduced Fas expression in a rat model of reversible cerebral ischemia when compared to normothermic controls . We measured the membrane-bound form of Fas, which is known to be of far greater importance in the apoptotic process than the soluble form of the molecule that was determined in previous studies [6, 8].
In conclusion, our data show that apoptosis signal cascade is activated at early stages in human myocardium during aortic valve replacement under ModHT CPB. This apoptosis induction can effectively be attenuated by a near-normothermic strategy. In our experience, the biochemical benefit of mild hypothermia is not apparently based on the reduction of bypass times or the use of less postoperative inotropic support, and should response to a direct impact of temperature on cell membrane stability and death receptor signaling pathway.
4.1. Limitations of the study
Heart tissue samples were harvested from the right atrial appendage with the intention of obtaining an appropriate amount of tissue without impairing cardiac function. This strategy has been previously reported for the study of apoptosis during CPB . Nevertheless, the distribution of the cardioplegia infused through the coronary sinus is not uniform in the entire heart, and left cavities may be better preserved than the right ones. The hypothesis that our findings in the right atrium mirror changes in the left ventricular muscle must be made with cautious and represents a limitation of the present work.
The percentage of cardiomyocytes that have initiated the apoptotic program at the time of first sample acquisition (preCPB) seems remarkably high in both groups (more than 16% in annexin assay, and more than 15% in Fas staining), which may indicate a lack of specificity of both techniques. Although tissue damage during biopsy collection might have contributed to artifact the results, we hypothesize that our data may reliably reflect the state of apoptosis in atrial myocardium just before CPB. In fact, contributing factors such us anesthesia induction, sternotomy, or cannulation may trigger the apoptotic cascade before the start of CPB, as it has been suggested by previous works . Besides, apoptosis is a reversible process until the downstream caspases (caspase-3, -6, -7) are activated , so not all the annexin positive-PI negative and Fas positive cells will necessarily complete the apoptotic program and die.
- Eefting F, Rensing B, Wigman J, Pannekoek WJ, Liu WM, Cramer MJ, Lips DJ, Doevedans PA: Role of apoptosis in reperfusion injury. Cardiovasc Res. 2004, 61: 414-26. 10.1016/j.cardiores.2003.12.023.View ArticlePubMedGoogle Scholar
- Khoynezhad A, Jalali Z, Tortolani AJ: Apoptosis: pathophysiology and therapeutic implications for the cardiac surgeon. Ann Thorac Surg. 2004, 78: 1109-18. 10.1016/j.athoracsur.2003.06.034.View ArticlePubMedGoogle Scholar
- Baumgartner WA, Walinsky PL, Salazar JD, Tseng EE, Brock MV, Doty JR, Redmond JM, Blue ME, Goldsborough MA, Troncoso JC, Johnston MV: Assessing the impact of cerebral injury after cardiac surgery: will determining the mechanism reduce this injury?. Ann Thorac Surg. 1999, 67: 1871-4. 10.1016/S0003-4975(99)00445-2.View ArticlePubMedGoogle Scholar
- Meldrum DR, Donnahoo KK: Role of TNF in mediating renal insufficiency following cardiac surgery: evidence of a post-bypass cardiorenal syndrome. J Surg Res. 1999, 85: 185-99. 10.1006/jsre.1999.5660.View ArticlePubMedGoogle Scholar
- Cooper WA, Duarte IG, Thourani VH, Nakamura M, Wang NP, Brown WM, Gott JP, Vinten-Johansen J, Guyton RA: Hypothermic circulatory arrest causes multisystem vascular endothelial dysfunction and apoptosis. Ann Thorac Surg. 2000, 69: 696-703. 10.1016/S0003-4975(99)01524-6.View ArticlePubMedGoogle Scholar
- Kawahito K, Misawa Y, Fuse K: Transient rise in serum soluble Fas (APO-1/CD95) in patients undergoing cardiac surgery. Artif Organs. 2000, 24: 628-31. 10.1046/j.1525-1594.2000.06591.x.View ArticlePubMedGoogle Scholar
- Aebert H, Kirchner S, Keyser A, Birnbaum DE, Holler E, Andreesen R, Eissner G: Endothelial apoptosis is induced by serum of patients after cardiopulmonary bypass. Eur J Cardiothorac Surg. 2000, 18: 589-93. 10.1016/S1010-7940(00)00565-0.View ArticlePubMedGoogle Scholar
- Joashi U, Tibby SM, Turner C, Mayer A, Austin C, Anderson C, Durward A, Murdoch IA: Soluble Fas may be a proinflammatory marker after cardiopulmonary bypass in children. J Thorac Cardiovasc Surg. 2002, 123: 137-44. 10.1067/mtc.2002.118685.View ArticlePubMedGoogle Scholar
- Schmitt JP, Schröder J, Schunkert H, Birnbaum DE, Aebert H: Role of apoptosis in myocardial stunning after open heart surgery. Ann Thorac Surg. 2002, 73: 1229-35. 10.1016/S0003-4975(02)03401-X.View ArticlePubMedGoogle Scholar
- Fischer UM, Tossios P, Huebner A, Geissler HJ, Bloch W, Mehlhorn U: Myocardial apoptosis prevention by radical scavenging in patients undergoing cardiac surgery. J Thorac Cardiovasc Surg. 2004, 128: 103-8. 10.1016/j.jtcvs.2003.11.034.View ArticlePubMedGoogle Scholar
- Scholz M, Simon A, Berg M, Schuller AM, Hacibayramogh M, Margraf S, Theisen A, Windolf J, Wimner-Greineker G, Moritz A: In vivo inhibition of neutrophil activity by a FAS (CD95) stimulating module: arterial in-line application in a porcine cardiac surgery model. J Thorac Cardiovasc Surg. 2004, 127: 1735-42. 10.1016/j.jtcvs.2003.09.027.View ArticlePubMedGoogle Scholar
- Leaes PE, Neumann J, Jung LA, Blacher C, Lucchese F, Clausell N: Lymphocyte's activation and apoptosis after coronary artery bypass graft: a comparative study of two membrane oxygenators, one with and another without a venous-arterial shunt. ASAIO J. 2004, 50: 611-8. 10.1097/01.MAT.0000144590.98621.4F.View ArticlePubMedGoogle Scholar
- Valen G: The basic biology of apoptosis and its implications for cardiac function and viability. Ann Thorac Surg. 2003, 75: S656-60. 10.1016/S0003-4975(02)04687-8.View ArticlePubMedGoogle Scholar
- Moudgil R, Menon R, Xu Y, Musat-Marcu S, Kumar D, Jugdutt BI: Postischemic apoptosis and functional recovery after angiotensin II type 1 receptor blockade in isolated working rat hearts. J Hypertens. 2001, 19: 1121-9. 10.1097/00004872-200106000-00018.View ArticlePubMedGoogle Scholar
- Kylarova D, Prochazkova J, Mad'arova J, Bartos J, Lichnovsky V: Comparison of the TUNEL, lamin B and annexin V methods for the detection of apoptosis by flow cytometry. Acta Histochem. 2002, 104: 367-70. 10.1078/0065-1281-00674.View ArticlePubMedGoogle Scholar
- Ning XH, Xu CS, Song YC, Xiao Y, Hu YJ, Lupinetti FM, Portman MA: Hypothermia preserves function and signalling for mitochondrial biogenesis during subsequent ischemia in isolated rabbit heart. Am J Physiol Heart Circ Physiol. 1998, 274: H786-H793.Google Scholar
- Tönz M, Mihaljevic T, von Segesser LK, Schmid ER, Joller-Jemelka HI, Pei P, Turina MI: Normothermia versus hypothermia during cardiopulmonary bypass: a randomized, controlled trial. Ann Thorac Surg. 1995, 59: 137-43. 10.1016/0003-4975(94)00718-M.View ArticlePubMedGoogle Scholar
- Lewis ME, Al-Khalidi AH, Townend JN, Coote J, Bonser RS: The effects of hypothermia on human left ventricular contractile function during cardiac surgery. J Am Coll Cardiol. 2002, 39: 102-8. 10.1016/S0735-1097(01)01694-1.View ArticlePubMedGoogle Scholar
- Ning XH, Chen SH, Xu CS, Li L, Yao LY, Qian K, Krueger JJ, Hyyti OM, Portman MA: Hypothermic protection of the ischemic heart via alterations in apoptotic pathways as assessed by gene array analysis. J Appl Physiol. 2002, 92: 2200-7.View ArticlePubMedGoogle Scholar
- Bossenmeyer-Pourie C, Koziel V, Daval JL: Effects of hypothermia on hypoxia-induced apoptosis in cultured neurons from developing rat forebrain: comparison with preconditioning. Pediatr Res. 2000, 47: 385-91.View ArticlePubMedGoogle Scholar
- Mizuno T, Miura-Suzuki T, Yamashita H, Mori N: Distinct regulation of brain mitochondrial carrier protein-1 and uncoupling protein-2 genes in the rat brain during cold exposure and aging. Biochem Biophys Res Commun. 2000, 278: 691-7. 10.1006/bbrc.2000.3859.View ArticlePubMedGoogle Scholar
- Phanithi PB, Yoshida Y, Santana A, Su M, Kawamura S, Yasui N: Mild hypothermia mitigates post-ischemic neuronal death following focal cerebral ischemia in rat brain: immunohistochemical study of Fas, caspase-3 and TUNEL. Neuropathology. 2000, 20: 273-282. 10.1046/j.1440-1789.2000.00346.x.View ArticlePubMedGoogle Scholar
- Dumont EA, Hofstra L, van Heerde WL, van Den ES, Doevendans PA, DeMuinck E, Daemen MA, Smits JF, Frederik P, Wellens HJ, Daemen MJ, Reutelingsperger CP: Cardiomyocyte death induced by myocardial ischemia and reperfusion: measurement with recombinant human Annexin-V in a mouse model. Circulation. 2000, 102: 1564-8.View ArticlePubMedGoogle Scholar
- Narayan P, Mentzer RM, Lasley RD: Annexin V staining during reperfusion detects cardiomyocytes with unique properties. Am J Physiol Heart Circ Physiol. 2001, 281: H1931-7.PubMedGoogle Scholar
- Tanaka M, Ito H, Adachi S, Akimoto H, Nishikawa T, Kasajima T, Marumo F, Hiroe M: Hypoxia induces apoptosis with enhaced expression of Fas antigen messenger RNA in cultured neonatal rat cardiomyocytes. Cir Res. 1994, 75: 426-33.View ArticleGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.